Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.06)
# 2,762
Out of 5,038 analysts
96
Total ratings
44.3%
Success rate
1.71%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRAL GRAIL | Maintains: Buy | $75 → $85 | $79.51 | +6.90% | 4 | Oct 22, 2025 | |
| WGS GeneDx Holdings | Initiates: Buy | $155 | $120.38 | +28.76% | 1 | Oct 20, 2025 | |
| VCYT Veracyte | Initiates: Hold | $40 | $34.84 | +14.81% | 1 | Oct 20, 2025 | |
| TEM Tempus AI | Initiates: Buy | $110 | $85.55 | +28.58% | 1 | Oct 20, 2025 | |
| NTRA Natera | Maintains: Buy | $200 | $190.50 | +4.99% | 9 | Oct 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $75 | $67.90 | +10.46% | 8 | Sep 26, 2025 | |
| BDSX Biodesix | Maintains: Buy | $30 → $20 | $6.24 | +220.51% | 5 | Sep 19, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1 | $2.25 | -55.56% | 4 | Sep 9, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 | $23.70 | +56.15% | 5 | Sep 9, 2025 | |
| QTRX Quanterix | Downgrades: Hold | $12 → $5 | $5.69 | -12.13% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $99 → $105 | $98.62 | +6.47% | 12 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $11 | $11.95 | -7.95% | 4 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $12.57 | +19.33% | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $150 | $159.41 | -5.90% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.86 | +61.29% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.22 | +146.91% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $63.55 | +18.02% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.42 | +373.37% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.44 | +11,171.48% | 1 | Mar 30, 2021 |
GRAIL
Oct 22, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $79.51
Upside: +6.90%
GeneDx Holdings
Oct 20, 2025
Initiates: Buy
Price Target: $155
Current: $120.38
Upside: +28.76%
Veracyte
Oct 20, 2025
Initiates: Hold
Price Target: $40
Current: $34.84
Upside: +14.81%
Tempus AI
Oct 20, 2025
Initiates: Buy
Price Target: $110
Current: $85.55
Upside: +28.58%
Natera
Oct 14, 2025
Maintains: Buy
Price Target: $200
Current: $190.50
Upside: +4.99%
Guardant Health
Sep 26, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $67.90
Upside: +10.46%
Biodesix
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $6.24
Upside: +220.51%
Quantum-Si incorporated
Sep 9, 2025
Maintains: Hold
Price Target: $1
Current: $2.25
Upside: -55.56%
Castle Biosciences
Sep 9, 2025
Maintains: Buy
Price Target: $37
Current: $23.70
Upside: +56.15%
Quanterix
Aug 11, 2025
Downgrades: Hold
Price Target: $12 → $5
Current: $5.69
Upside: -12.13%
Aug 1, 2025
Maintains: Hold
Price Target: $99 → $105
Current: $98.62
Upside: +6.47%
Jul 30, 2025
Maintains: Buy
Price Target: $8 → $11
Current: $11.95
Upside: -7.95%
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $12.57
Upside: +19.33%
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $159.41
Upside: -5.90%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.86
Upside: +61.29%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.22
Upside: +146.91%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $63.55
Upside: +18.02%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.42
Upside: +373.37%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.44
Upside: +11,171.48%